Randomized, controlled trial of the long term safety, immunogenicity and efficacy of RTS,S/AS02<sub>D</sub> malaria vaccine in infants living in a malaria-endemic region

Randomized, controlled trial of the long term safety, immunogenicity and efficacy of RTS,S/AS02<sub>D</sub> malaria vaccine in infants living in a malaria-endemic region

<p>Abstract</p> <p>Background</p> <p>The RTS,S/AS malaria candidate vaccine is being developed with the intent to be delivered, if approved, through the Expanded Programme on Immunization (EPI) of the World Health Organization. Safety, immunogenicity and efficacy of the...

Full description

Bibliographic Details
Main Authors: Abdulla Salim, Salim Nahya, Machera Francisca, Kamata Richard, Juma Omar, Shomari Mwanajaa, Kubhoja Sulende, Mohammed Ali, Mwangoka Grace, Aebi Thomas, Mshinda Hassan, Schellenberg David, Carter Terrell, Villafana Tonya, Dubois Marie-Claude, Leach Amanda, Lievens Marc, Vekemans Johan, Cohen Joe, Ballou W Ripley, Tanner Marcel
Format: Article
Language:English
Published: BMC 2013-01-01
Series:Malaria Journal
Subjects:
RTS,S/AS02
<it>Falciparum</it>
Malaria
Infants
Immunogenicity
Safety
Efficacy
EPI
Online Access:http://www.malariajournal.com/content/12/1/11

Internet

http://www.malariajournal.com/content/12/1/11

Similar Items